DE69330672D1 - Pharmazeutische zubereitung zur anwendung in den atemwegen - Google Patents

Pharmazeutische zubereitung zur anwendung in den atemwegen

Info

Publication number
DE69330672D1
DE69330672D1 DE69330672T DE69330672T DE69330672D1 DE 69330672 D1 DE69330672 D1 DE 69330672D1 DE 69330672 T DE69330672 T DE 69330672T DE 69330672 T DE69330672 T DE 69330672T DE 69330672 D1 DE69330672 D1 DE 69330672D1
Authority
DE
Germany
Prior art keywords
airway
pharmaceutical preparation
application
intra
starch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69330672T
Other languages
English (en)
Other versions
DE69330672T2 (de
Inventor
Yuji Makino
Hideki Kobayashi
Yoshiki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Pharma Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15564710&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69330672(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teijin Ltd filed Critical Teijin Ltd
Publication of DE69330672D1 publication Critical patent/DE69330672D1/de
Application granted granted Critical
Publication of DE69330672T2 publication Critical patent/DE69330672T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69330672T 1992-06-12 1993-06-11 Pharmazeutische zubereitung zur anwendung in den atemwegen Expired - Lifetime DE69330672T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15353892 1992-06-12
PCT/JP1993/000785 WO1993025193A1 (en) 1992-06-12 1993-06-11 Pharmaceutical preparation for intra-airway administration

Publications (2)

Publication Number Publication Date
DE69330672D1 true DE69330672D1 (de) 2001-10-04
DE69330672T2 DE69330672T2 (de) 2002-06-27

Family

ID=15564710

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330672T Expired - Lifetime DE69330672T2 (de) 1992-06-12 1993-06-11 Pharmazeutische zubereitung zur anwendung in den atemwegen

Country Status (10)

Country Link
US (1) US5626871A (de)
EP (1) EP0606486B1 (de)
KR (1) KR100208979B1 (de)
AT (1) ATE204750T1 (de)
AU (1) AU660824B2 (de)
CA (1) CA2115444C (de)
DE (1) DE69330672T2 (de)
ES (1) ES2159524T3 (de)
TW (2) TW272132B (de)
WO (1) WO1993025193A1 (de)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993805A (en) * 1991-04-10 1999-11-30 Quadrant Healthcare (Uk) Limited Spray-dried microparticles and their use as therapeutic vehicles
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
ES2177544T3 (es) * 1992-06-12 2002-12-16 Teijin Ltd Polvo ultrafinno para inhalar y metodo para su preparacion.
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
US6509006B1 (en) 1992-07-08 2003-01-21 Inhale Therapeutic Systems, Inc. Devices compositions and methods for the pulmonary delivery of aerosolized medicaments
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
US5354934A (en) † 1993-02-04 1994-10-11 Amgen Inc. Pulmonary administration of erythropoietin
ATE264096T1 (de) * 1994-03-07 2004-04-15 Nektar Therapeutics Verfahren und mittel zur verabreichung von insulin über die lunge
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
BR9509171A (pt) * 1994-09-29 1997-09-16 Andaris Ltd Microparticulas secas por borrifamento como veículos terapêuticos
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) * 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US6428771B1 (en) 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
DK0943326T4 (da) * 1996-02-27 2007-01-22 Teijin Ltd Pulveragtigt præparat til nasal administration
GB9607035D0 (en) * 1996-04-03 1996-06-05 Andaris Ltd Spray-dried microparticles as therapeutic vehicles
JP3020141B2 (ja) * 1996-10-07 2000-03-15 株式会社富士薬品 経鼻投与用製剤
US6068600A (en) * 1996-12-06 2000-05-30 Quadrant Healthcare (Uk) Limited Use of hollow microcapsules
DE19652196A1 (de) * 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6183169B1 (en) * 1998-08-13 2001-02-06 The University Of Western Ontario Precision dispensing of ultra-fines via a gas medium
US6835389B1 (en) 1998-08-26 2004-12-28 Teijin Limited Powder Composition for nasal administration
US6635275B1 (en) 1999-01-29 2003-10-21 Warner-Lambert Company Modified starch film compositions
EP1117736B2 (de) * 1998-09-30 2008-08-13 Warner-Lambert Company LLC Filmbildende zusammensetzungen aus modifizierter stärke
WO2001000654A2 (en) 1999-06-29 2001-01-04 Pharmaceutical Discovery Corporation Purification and stabilization of peptide and proteins in pharmaceutical agents
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ITMI991582A1 (it) 1999-07-16 2001-01-16 Chiesi Farma Spa Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala
US6651655B1 (en) * 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
CN100551358C (zh) 2000-06-27 2009-10-21 维克多瑞有限公司 用于药物组合物的颗粒的制备方法
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
DE60230609D1 (de) * 2001-05-24 2009-02-12 Alexza Pharmaceuticals Inc Verabreichung von nichtsteroidalen entzündungshemmenden wirkstoffen durch inhalation
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
AU2002305780A1 (en) 2001-05-29 2002-12-09 Transchip, Inc. Patent application cmos imager for cellular applications and methods of using such
US7738013B2 (en) * 2001-05-29 2010-06-15 Samsung Electronics Co., Ltd. Systems and methods for power conservation in a CMOS imager
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
AU2002363947A1 (en) 2001-11-21 2003-07-24 Alexza Molecular Delivery Corporation Delivery of caffeine through an inhalation route
AU2002351271A1 (en) * 2001-12-21 2003-07-24 Nektar Therapeutics Capsule package with moisture barrier
TW200305443A (en) * 2002-03-07 2003-11-01 Novartis Ag Pharmaceutical compositions
DE60318938T2 (de) 2002-03-20 2009-01-22 Mannkind Corp., Valencia Inhalationsgerät
CA2483687A1 (en) 2002-05-13 2003-11-20 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
EP1417961A1 (de) * 2002-11-08 2004-05-12 Boehringer Ingelheim International GmbH Neue pharmazeutische Zubereitung enthaltend eine Kombination von Ambroxol oder Bromhexin und Isopropamid Jodid
CN1717237A (zh) 2002-11-26 2006-01-04 艾利斯达分子传输公司 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7550133B2 (en) 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JPWO2004075920A1 (ja) 2003-02-26 2006-06-01 大塚製薬株式会社 経肺投与用徐放性製剤学的組成物
US7591999B2 (en) * 2003-03-04 2009-09-22 Mitsubishi Tanabe Pharma Corporation Powdery preparation for nasal administration
US20060254583A1 (en) * 2003-03-20 2006-11-16 Arthur Deboeck Dry powder inhaler system
US7816341B2 (en) 2003-04-14 2010-10-19 Fmc Corporation Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
JP2006526057A (ja) 2003-04-14 2006-11-16 エフ　エム　シー　コーポレーション 均一で熱可逆性の低粘度ポリマンナンガムフィルム及びそれからつくったソフトカプセル
US7068446B2 (en) * 2003-05-05 2006-06-27 Illumitech Inc. Compact non-imaging light collector
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
US20050042178A1 (en) * 2003-08-18 2005-02-24 Boehringer Ingelheim International Gmbh Microparticles containing the CGRP-antagonist 1-[N2-[3,5-dibrom-N-[[4-(3,4-dihydro-2(1H)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine, process for preparing and the use thereof as inhalation powder
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1786784B1 (de) 2004-08-20 2010-10-27 MannKind Corporation Katalyse der diketopiperazinsynthese
CA2578175C (en) 2004-08-23 2014-10-14 Mannkind Corporation Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
ES2399053T3 (es) 2004-10-11 2013-03-25 Nasaleze Patents Limited Composiciones para administración intranasal
CA2583794C (en) * 2004-10-11 2015-05-26 Nasaleze Ppm Limited Compositions for intranasal administration
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
EP1762232A1 (de) * 2005-09-09 2007-03-14 Warner-Lambert Company LLC Flüssigkeit gefüllte Zufuhrsystem, vorzugweise ein HPMC Kapsel gefüllt mit Glycerol
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
BRPI0707991B8 (pt) 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
CA2649109A1 (en) 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
EP2570147B1 (de) 2008-06-13 2017-10-18 MannKind Corporation Trockenpulverinhalator und System zur Wirkstofffreisetzung
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP3578169B1 (de) 2009-02-26 2024-06-26 Glaxo Group Limited Pharmazeutische formulierungen enthaltend 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
PL2405963T3 (pl) 2009-03-11 2014-04-30 Mannkind Corp Urządzenie, układ i sposób pomiaru oporu inhalatora
KR20180079458A (ko) 2009-06-12 2018-07-10 맨카인드 코포레이션 한정된 비표면적을 갖는 디케토피페라진 마이크로입자
EP2496295A1 (de) 2009-11-03 2012-09-12 MannKind Corporation Vorrichtung und verfahren zur simulation von einatmungsanstrengungen
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
CN105667994B (zh) 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
CN108057154B (zh) 2012-07-12 2021-04-16 曼金德公司 干粉药物输送系统和方法
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
CA2906817C (en) 2013-03-15 2022-01-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
JP2016530930A (ja) 2013-08-05 2016-10-06 マンカインド コーポレイション 通気装置及び方法
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
CN115461045A (zh) 2020-04-22 2022-12-09 比利时胶囊公司 粉末保留率降低的hpmc胶囊

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4161517A (en) * 1977-11-28 1979-07-17 General Mills, Inc. Plaque inhibiting composition and method
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS5934267A (ja) * 1982-08-23 1984-02-24 帝人株式会社 粉状薬剤施薬装置
JPS61100519A (ja) * 1984-10-23 1986-05-19 Shin Etsu Chem Co Ltd 医薬用硬質カプセル
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
GB2193891B (en) * 1986-08-18 1990-07-25 Sandoz Ltd Nasal pharmaceutical composition containing a somatostatin anologue.

Also Published As

Publication number Publication date
TW283649B (de) 1996-08-21
EP0606486A1 (de) 1994-07-20
AU660824B2 (en) 1995-07-06
WO1993025193A1 (en) 1993-12-23
TW272132B (de) 1996-03-11
EP0606486B1 (de) 2001-08-29
ATE204750T1 (de) 2001-09-15
CA2115444A1 (en) 1993-12-23
EP0606486A4 (en) 1996-10-23
DE69330672T2 (de) 2002-06-27
ES2159524T3 (es) 2001-10-16
AU4355593A (en) 1994-01-04
US5626871A (en) 1997-05-06
KR100208979B1 (ko) 1999-07-15
CA2115444C (en) 2000-10-03

Similar Documents

Publication Publication Date Title
DE69330672T2 (de) Pharmazeutische zubereitung zur anwendung in den atemwegen
ID28003A (id) Turunan-turunan adamantana
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
ATE109145T1 (de) Heterozyklische acylaminothiazolderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
FI942181A (fi) Uudet lupaanijohdannaiset, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
IL110481A0 (en) 1-Benzenesulfonyl-1,3-dihydro-2h-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them
EE9900075A (et) 7a-( -aminoalküül)östratrieenid, nende valmistamise meetod, 7a-( -aminoalküül)östratrieene sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks
CZ285522B6 (cs) Farmaceutický prostředek pro snížení koncentrace glukosy v krvi
DE122006000065I1 (de) Cephalosporine und ihre homologen, zubereitungen und Pharmazeutische Pr{parate
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
EP0448091A3 (en) Pharmaceutical composition containing slightly water-soluble drug
DE50003454D1 (de) Proteinenthaltende pharmazeutische zubereitung
IL105942A0 (en) Biologically active eburnamenine derivatives,their preparation and pharmaceutical compositions containing them
ATA214588A (de) Pharmazeutische dosierungsform zur kontrollierten abgabe von diltiazem
IL90911A0 (en) Amidino and guanidino derivatives,their preparation and pharmaceutical compositions containing them
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
IL98569A0 (en) Pharmaceutical compositions containing tgf-b and antagonists thereof for modulating blood pressure
DE69002822D1 (de) Pharmazeutische zubereitung zur oralen verabreichung in fluessiger form.
GB9014871D0 (en) Drug delivery system for administering growth factor
EE04347B1 (et) 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, neid sisaldav ravim ja farmatseutiline kompositsioon
NO302360B1 (no) NG-monometyl-L-argininhydrokloridderivater
IL92441A (en) Imidazole containing peptides, their preparation and pharmaceutical compositions containing them
ES2128966A1 (es) Composiciones farmaceuticas parenterales a base de calcitoninas sinteticas, de ph controlado, con bajo indice de dolor y buena estabilidad.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: TEIJIN PHARMA LTD., TOKIO/TOKYO, JP

8365 Fully valid after opposition proceedings